Multidisciplinary Support for a Successful ODD Application

Published on: Feb 24th, 2020

A US biopharmaceutical client had to withdraw their ODD application during the COMP’s review procedure, due to the lack of substantial clinical data, as anticipated in VCLS’ feasibility assessment.
Two years on, the client asked VCLS to provide expertise to identify the gaps in the studies and recommend a new approach.